SCHEMBL6980280

SCHEMBL6980280

c1ccc2c(c1)OCCN2CCCCN1CCN2CCCCC2C1

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.49
SLC6A4 P31645 1/20 0.49
SIGMAR1 Q99720 5/20 0.45
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
TMEM97 Q5BJF2 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2B Q13224 1/20 0.42
KCNH2 Q12809 1/20 0.41
ABCB1 P08183 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5841481 0.99 HTR1A (0.48) HTR1ASLC6A4SIGMAR1TSHRKMT2A
SCHEMBL5841552 0.81 GRIN1 (0.55) SIGMAR1KMT2ATMEM97GRIN1GRIN2B
SCHEMBL6986329 0.80 GRIN1 (0.57) HTR1AGRIN1GRIN2BKCNH2
SCHEMBL5842866 0.80 GRIN1 (0.54) SIGMAR1KMT2ATMEM97GRIN1GRIN2B
Hydrochloric Acid SCHEMBL5840866 0.80 GRIN1 (0.54) SIGMAR1KMT2ATMEM97GRIN1GRIN2B
Hydrochloric Acid SCHEMBL5842816 0.79 GRIN1 (0.56) HTR1AGRIN1GRIN2BKCNH2
Hydrochloric Acid SCHEMBL5841279 0.79 GRIN1 (0.53) SIGMAR1KMT2AGRIN1GRIN2B
SCHEMBL11805707 0.73 HTR1A (0.52) HTR1ASLC6A4SIGMAR1TSHRKMT2A
SCHEMBL31033183 0.71 KMT2A (0.56) HTR1ASLC6A4SIGMAR1TSHRKMT2A
SCHEMBL9247991 0.71 HTR1A (0.56) HTR1ASLC6A4TSHRKMT2AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1275647-B1 Octahydro-2H-pyrido[1,2-a]pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2003-11-12 EP disclosed
EP-1275647-A1 Octahydro-2H-pyrido[1,2-a]pyrazine derivatives, process for their preparation and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2003-01-15 EP disclosed